Prediction of prognosis, efficacy of lung adenocarcinoma by machine learning model based on immune and metabolic related genes by Cong Xue, Yi-Zhi Dai, Gui-Long Li, Yi Zhang

Get full text

Online Task Switching and Scheduling Method for Attitude–Orbit–Shape-Distributed Control of Large Space Ring Structures by Shuo Han, Miao Wang, Cong Xue, Weiran Yao, Guanghui Sun

Get full text

Time-series forest age estimation in Xinjiang based on forest disturbance and recovery detection by Lili Zhai, Mei Zan, Mao Ye, Jia Zhou, Cong Xue, Shunfa Yang, Yuntong Liu

Get full text

The transcription factor YbdO attenuates the pathogenicity of avian pathogenic Escherichia coli by regulating oxidative stress response by Lumin Yu, Yuzhong Zhao, Shanpeng Zhang, Linan Xu, Su Tang, Yuxuan Geng, Cong Xue, Xinglin Zhang

Get full text

Antimicrobial resistance and virulence factors analysis of a multidrug-resistant Acinetobacter baumannii isolated from chickens using whole-genome sequencing by Lumin Yu, Yuzhong Zhao, Shanpeng Zhang, Weishi Ni, Lingling Zhang, Cong Xue, Peikun Wang, Xinglin Zhang

Get full text

Efficacy and safety of modified bleomycin administration with EP chemotherapy in adult male patients with germ cell tumors: a retrospective study by Ditian Shu, Riqing Huang, Meiting Chen, Haifeng Li, Xin An, Cong Xue, Anqi Hu, Fangjian Zhou, Kai Yao, Zhuowei Liu, Yanxia Shi

Get full text

Clinical outcome and genomic biomarkers of immune checkpoint inhibitor-based therapies for cancer of unknown primary: a multicenter, real-world study by Yunjie Huang, Riqing Huang, Meiting Chen, Zhousan Zheng, Haifeng Li, Rishang Chen, Tinghua Gao, Ditian Shu, Anqi Hu, Qiufan Zheng, Xin An, Yanxia Shi, Cong Xue

Get full text

Bevacizumab, tislelizumab and nab-paclitaxel for previously untreated metastatic triple-negative breast cancer: a phase II trial by Wei Yang, Qi Sun, Fei Xu, Jing Peng, Cong Xue, Meiting Chen, Riqing Huang, Qixiang Rong, Xiujiao Shen, Ditian Shu, Kuikui Jiang, Xin An, Haifeng Li, Yanxia Shi

Get full text

PD‐1/PD‐L1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone as First‐Line Therapy for Patients With Unfavorable Cancer of Unknown Primary: A Multicenter, Retrospective Cohort... by Riqing Huang, Haifeng Li, Shuo Li, Ditian Shu, Rishang Chen, Zhousan Zheng, Tinghua Gao, Meiting Chen, Anqi Hu, Yunjie Huang, Qiufan Zheng, Xin An, Cong Xue, Yuchen Cai, Yanxia Shi

Get full text

CYP2D6 polymorphisms and endoxifen concentration in Chinese patients with breast cancer by Cong Xue, Wei Yang, Anqi Hu, Caiyun He, Hai Liao, Meiting Chen, Xin An, Shusen Wang, Zhongyu Yuan, Fei Xu, Jun Tang, Haifeng Li, Su Li, Jianyong Shao, Yanxia Shi

Get full text

Incidence of Metastasis in the Central Nervous System in Advanced Breast Cancer Treated With CDK 4/6 Inhibitors: A Multicenter, Retrospective Study by Yan‐Ling Wen, Xi‐Wen Bi, Xue‐Wen Zhang, Si‐Fen Wang, Chang Jiang, Li Wang, Yong‐Yi Zhong, Yuan‐Yuan Huang, Jian‐Li Zhao, Qian‐Jun Chen, Cong Xue, Zhong‐Yu Yuan

Get full text

Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations. by Wenhua Liang, Xuan Wu, Wenfeng Fang, Yuanyuan Zhao, Yunpeng Yang, Zhihuang Hu, Cong Xue, Jing Zhang, Jianwei Zhang, Yuxiang Ma, Ting Zhou, Yue Yan, Xue Hou, Tao Qin, Xiaoxiao Dinglin, Ying Tian, Peiyu Huang, Yan Huang, Hongyun Zhao, Li Zhang

Get full text